Delays in Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Magnitude and Institutional Barriers in Tanzania

Author:

Abstract

Background: Multi-drug-resistant tuberculosis (MDR-TB) poses significant challenges in timely diagnosis and treatment due to various institutional barriers. Effective management of MDR-TB requires addressing these barriers to improve patient outcomes. This study aimed to assess the magnitude of delays in the diagnosis and treatment of MDR-TB and identify associated institutional barriers in Tanzania. Methodology: A descriptive cross-sectional survey was conducted at three major healthcare facilities: the Central Tuberculosis Reference Laboratory (CTRL), Kibong’oto National TB Hospital, and regional hospitals in Mwanza and Mbeya, from January to April 2017. A total of 200 MDR-TB patients were randomly selected from hospital records, and 12 key informants were purposively chosen. Quantitative data were collected using a modified WHO questionnaire, while qualitative data were obtained through key informant interviews. Data were analyzed using SPSS version 22 for quantitative analysis and NVivo software for qualitative analysis. Diagnostic delay was categorized based on a 21-day cutoff. Results: Of the 200 approached MDR-TB patients, 192 provided complete responses (96.0% response rate). The mean age of respondents was 39.52 years (SD 12.87). Diagnostic delays were observed in 72.40% of the patients. Factors associated with delays included multiple hospital visits before diagnosis, longer consultation turnaround times, lack of health education, delayed laboratory results, payment methods (cash vs. insurance), and distance to diagnostic centers. Qualitative data revealed misdiagnosis, inadequate counseling, frequent breakdowns of diagnostic equipment, and individual-level barriers as significant contributors to delays. Conclusions: The study found that a majority of MDR-TB patients experienced diagnostic delays, with multiple institutional and individual factors contributing to these delays. Addressing issues such as misdiagnosis, inadequate health education, and logistical barriers, along with improving diagnostic infrastructure and reducing financial and distance-related barriers, could enhance timely diagnosis and treatment of MDR-TB in Tanzania.

Publisher

Uniscience Publishers LLC

Reference25 articles.

1. Seung, K. J., Keshavjee, S., & Rich, M. L. (2015, Apr 27). Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med., 5(9), a017863. DOI: https://doi.org/10.1101/cshperspect.a017863

2. Xi, Y., Zhang, W., Qiao, R-J., & Tang, J. (2022). Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS ONE, 17(6), e0270003. DOI: https://doi.org/10.1371/journal.pone.0270003

3. Salari, N., Kanjoori, A.H., Hosseinian-Far, A., Hasheminezhad, R., Mansouri, K., & Mohammadi, M. (2023). Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty, 12(1), 57. DOI: https://doi.org/10.1186/s40249-023-01107-x

4. Kilale, A. M., Pantoja, A., Jani, B., Range, N., Ngowi, B. J., Makasi, C., Majaha, M., Manga, C. D., Haule, S., Wilfred, A., Hilary, P., Mahamba, V., Nkiligi, E., Muhandiki, W., Matechi, E., Mutayoba, B., Nishkiori, N., & Ershova, J. (2022 Mar 29). Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. BMC Public Health, 22(1), 600. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-12987-3#:~:text=Of%20the%20777%20TB%2Daffected,and%20medical%20costs%20(15.1%25).

5. Paleckyte, A., Dissanayake, O., Mpagama, S., Lipman, M. L., & McHugh, T. D. (2021). Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrob Resist Infect Control 10(1), 106. DOI: https://doi.org/10.1186/s13756-021-00975-y

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3